Scalpel Weekly News

Week of: August 25, 2014

IN THE NEWS


Hyaluraonic Acid Gel Product Recall-Incorrect Concentration, Bubbling; Plus Unapproved Use

All lots of Expression 1.5cc gel, manufactured between August 15, 2012, and June 27, 2014, have been recalled because the manufacturer, Enhancement Medical, cannot ensure that Expression contains the correct concentration of hyaluronic acid. Incorrect concentration of hyaluronic acid may result in injury. Click title to continue reading...


 
MEDICAL ALERTS


FDA Warns Consumers About Fraudulent Ebola Treatments

The FDA is advising consumers to be aware of products sold online claiming to prevent or treat the Ebola virus. Since the outbreak of the Ebola virus in West Africa, the FDA has seen and received consumer complaints about a variety of products claiming to either prevent the Ebola virus or treat the infection. Click title to continue reading...



Guilty Plea For Importing Illegal Cancer Drugs

The owner of the Istanbul, Turkey, firm Ozay Pharmaceuticals, has pleaded guilty to charges of smuggling misbranded and adulterated cancer treatment drugs into the United States. He pleaded guilty in the U.S. District Court for the Eastern District of Missouri, in St. Louis, Missouri, where he initially shipped his illegal drugs. The drugs did not meet the FDA’s standards and had not been approved for distribution in the United States. Click title to continue reading...



Chicago Health Department Uses Social Media To Identify Foodborne Illness

An estimated 55 million to 105 million persons in the United States experience acute gastroenteritis caused by foodborne illness each year, resulting in costs of $2-$4 billion annually. Many persons do not seek treatment, resulting in underreporting of the actual number of cases and cost of the illnesses. Click title to continue reading...


  CASE ALERTS


Expert’s Statements On Causation Conclusory In Failure To Diagnose Cancer Case

A man presented to an outpatient family physician with low back pain that began approximately two weeks prior to the visit. The outpatient family physician ordered radiographic imaging, an MRI, various lab tests, and prescribed Lortab for his pain symptoms. His lab tests showed an elevated sed rate of 30 (normal is 0–15), elevated BUN at 27, and also elevated creatinine and calcium levels. Click title to continue reading...



Expert Unreliable on Standard of Care; Had Not Performed Procedure or Been Trained, and Did Not Cite Authority

A woman underwent a dilation and curettage (D & C), a procedure during which a curette—a sharp metal instrument—is used to scrape an area in the uterus, to remove polyps. Prior to curetting, the OB/GYN rechecked the placement of the Essure devices. An Essure device consisted of a coil, described as an almost slinky type looking object, which was placed in each fallopian tube, near the opening to the uterus. After placement of the coils, over a period of three months, scar tissue formed around the coils, occluding the tubes and preventing sperm from passing through and permanently sterilizing the woman. Click title to continue reading...



Expert on Causation Required for Negligent Failure to Provide Medical Insurance

A company hired an employee and in the first few days of his employment, the employee submitted application forms to enroll in the health insurance plans the company offered. Four months after he was hired, the employee noticed that health insurance premiums were not being deducted from his paychecks, and he so informed the company's benefits coordinator. The benefits coordinator gave him a second set of enrollment forms for him to complete. Insurance premiums began to be deducted from his paychecks, paying for coverage retroactive to when he notified the company’s benefits coordinator that the premiums were not being deducted. Premiums continued to be deducted until the employee quit working for the company about a month later. Click title to continue reading...